23andMe vs. the FDA part 3 – Lessons for start-ups
This blog post was written by Deniz Temelli, Business Analyst at TechAlliance. Late last fall genetics testing company 23andMe was ordered to stop marketing and selling their Personal Genome Service by the FDA (recap in my last blog post here). The company soon complied and limited their services to providing only ancestry related information. However,…